• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构激活和抑制葡萄糖激酶的突变分析。

Mutational analysis of allosteric activation and inhibition of glucokinase.

机构信息

Department of Biochemistry and Biophysics and Diabetes Research Center, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Biochem J. 2011 Dec 1;440(2):203-15. doi: 10.1042/BJ20110440.

DOI:10.1042/BJ20110440
PMID:21831042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4005413/
Abstract

GK (glucokinase) is activated by glucose binding to its substrate site, is inhibited by GKRP (GK regulatory protein) and stimulated by GKAs (GK activator drugs). To explore further the mechanisms of these processes we studied pure recombinant human GK (normal enzyme and a selection of 31 mutants) using steady-state kinetics of the enzyme and TF (tryptophan fluorescence). TF studies of the normal binary GK-glucose complex corroborate recent crystallography studies showing that it exists in a closed conformation greatly different from the open conformation of the ligand-free structure, but indistinguishable from the ternary GK-glucose-GKA complex. GKAs did activate and GKRP did inhibit normal GK, whereas its TF was doubled by glucose saturation. However, the enzyme kinetics, GKRP inhibition, TF enhancement by glucose and responsiveness to GKA of the selected mutants varied greatly. Two predominant response patterns were identified accounting for nearly all mutants: (i) GK mutants with a normal or close to normal response to GKA, normally low basal TF (indicating an open conformation), some variability of kinetic parameters (k(cat), glucose S(0.5), h and ATP K(m)), but usually strong GKRP inhibition (13/31); and (ii) GK mutants that are refractory to GKAs, exhibit relatively high basal TF (indicating structural compaction and partial closure), usually show strongly enhanced catalytic activity primarily due to lowering of the glucose S(0.5), but with reduced or no GKRP inhibition in most cases (14/31). These results and those of previous studies are best explained by envisioning a common allosteric regulator region with spatially non-overlapping GKRP- and GKA-binding sites.

摘要

GK(葡萄糖激酶)通过葡萄糖与其底物结合位点的结合而被激活,被 GKRP(葡萄糖激酶调节蛋白)抑制,被 GKAs(葡萄糖激酶激活剂药物)刺激。为了进一步探索这些过程的机制,我们使用酶的稳态动力学和 TF(色氨酸荧光)研究了纯重组人 GK(正常酶和 31 种突变体的选择)。TF 研究正常二元 GK-葡萄糖复合物证实了最近的晶体学研究,表明它存在于一种与无配体结构的开放构象大不相同的封闭构象,但与三元 GK-葡萄糖-GKA 复合物无法区分。GKAs 确实激活了正常 GK,而 GKRP 则抑制了正常 GK,而葡萄糖则使 TF 增加了一倍。然而,所选突变体的酶动力学、GKRP 抑制、葡萄糖对 TF 的增强以及对 GKA 的反应性差异很大。确定了两种主要的反应模式,几乎可以解释所有的突变体:(i)对 GKA 具有正常或接近正常反应的 GK 突变体,正常的 TF 基础值(表示开放构象)较低,动力学参数(k(cat)、葡萄糖 S(0.5)、h 和 ATP K(m))的某些可变性,但通常具有强烈的 GKRP 抑制(13/31);和(ii)对 GKA 无反应的 GK 突变体,表现出相对较高的基础 TF(表示结构紧凑和部分关闭),通常表现出强烈增强的催化活性,主要是由于降低了葡萄糖 S(0.5),但在大多数情况下降低了 GKRP 抑制(14/31)。这些结果和以前的研究结果最好通过设想一个具有空间上不重叠的 GKRP 和 GKA 结合位点的共同变构调节剂区域来解释。

相似文献

1
Mutational analysis of allosteric activation and inhibition of glucokinase.变构激活和抑制葡萄糖激酶的突变分析。
Biochem J. 2011 Dec 1;440(2):203-15. doi: 10.1042/BJ20110440.
2
Analysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescence.利用色氨酸荧光分析别构调节蛋白 GK 和 GKRP 之间的协同相互作用。
Biochem J. 2014 May 1;459(3):551-64. doi: 10.1042/BJ20131363.
3
Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.葡萄糖、小分子激活剂和葡萄糖激酶调节蛋白对葡萄糖激酶的调节:稳态动力学和基于细胞的分析。
Biochem J. 2012 Feb 1;441(3):881-7. doi: 10.1042/BJ20110721.
4
Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations.天然发生的突变中葡萄糖激酶激活的生化基础及葡萄糖激酶调节蛋白的调控
J Biol Chem. 2006 Dec 29;281(52):40201-7. doi: 10.1074/jbc.M607987200. Epub 2006 Nov 2.
5
Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea.葡萄糖激酶(GK)的热稳定性受底物葡萄糖、变构葡萄糖激酶激活剂药物(GKA)以及渗透剂甘油和尿素的影响。
Biochim Biophys Acta. 2012 May;1824(5):769-84. doi: 10.1016/j.bbapap.2012.03.003. Epub 2012 Mar 16.
6
Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.葡萄糖激酶调节蛋白作为葡萄糖激酶变构开关的分子基础。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10171-6. doi: 10.1073/pnas.1300457110. Epub 2013 Jun 3.
7
Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states.葡萄糖和变构激活剂与人葡萄糖激酶的结合动力学揭示了多种构象状态。
Biochemistry. 2009 Jun 16;48(23):5466-82. doi: 10.1021/bi900374c.
8
An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism.葡萄糖激酶的变构激活剂会破坏葡萄糖激酶与葡萄糖激酶调节蛋白之间的相互作用,并调节葡萄糖代谢。
J Biol Chem. 2006 Dec 8;281(49):37668-74. doi: 10.1074/jbc.M605186200. Epub 2006 Oct 6.
9
Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.恢复葡萄糖激酶活性的小分子葡萄糖激酶调节蛋白调节剂的发现。
J Biomol Screen. 2014 Aug;19(7):1014-23. doi: 10.1177/1087057114530468. Epub 2014 Apr 9.
10
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.葡萄糖激酶调节蛋白突变的小鼠表现出肝脏葡萄糖激酶减少:代谢调节中的一种隔离机制。
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14511-6. doi: 10.1073/pnas.96.25.14511.

引用本文的文献

1
In silico design of dehydrophenylalanine containing peptide activators of glucokinase using pharmacophore modelling, molecular dynamics and machine learning: implications in type 2 diabetes.利用药效团建模、分子动力学和机器学习对含脱氢苯丙氨酸的葡萄糖激酶肽激活剂进行计算机辅助设计:对2型糖尿病的影响
J Comput Aided Mol Des. 2024 Dec 31;39(1):5. doi: 10.1007/s10822-024-00583-z.
2
Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients.葡萄糖激酶变异蛋白对年轻起病的 2 型糖尿病患者的空腹诱导的尿苷二磷酸葡萄糖依赖性降解有抵抗作用。
Int J Mol Sci. 2023 Oct 31;24(21):15842. doi: 10.3390/ijms242115842.
3

本文引用的文献

1
Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators.在小鼠中生成 N-乙基-N-亚硝脲(ENU)糖尿病模型表明葡萄糖激酶激活剂具有特定的基因型作用。
J Biol Chem. 2011 Nov 11;286(45):39560-72. doi: 10.1074/jbc.M111.269100. Epub 2011 Sep 15.
2
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.用于糖尿病治疗的葡萄糖激酶激活剂的研发:理论与实践层面
Handb Exp Pharmacol. 2011(203):357-401. doi: 10.1007/978-3-642-17214-4_15.
3
Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase.
Pathogenic variants of Alport syndrome and monogenic diabetes identified by exome sequencing in a family.
通过外显子组测序在一个家族中鉴定出的奥尔波特综合征和单基因糖尿病的致病变异。
Hum Genome Var. 2023 Feb 2;10(1):5. doi: 10.1038/s41439-023-00233-0.
4
Localized islet nuclear enlargement hyperinsulinism (LINE-HI) due to ABCC8 and GCK mosaic mutations.局部胰岛细胞核增大性高胰岛素血症(LINE-HI)与 ABCC8 和 GCK 镶嵌突变有关。
Eur J Endocrinol. 2022 Jun 27;187(2):301-313. doi: 10.1530/EJE-21-1095. Print 2022 Aug 1.
5
The novel GCK variant p.Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes.与高胰岛素血症相关的新型 GCK 变异 p.Val455Leu 易受变构激活影响,有利于体重增加和糖尿病的发展。
Diabetologia. 2021 Dec;64(12):2687-2700. doi: 10.1007/s00125-021-05553-w. Epub 2021 Sep 16.
6
A novel reverse two-hybrid method for the identification of missense mutations that disrupt protein-protein binding.一种用于鉴定破坏蛋白质-蛋白质结合的错义突变的新型反向双杂交方法。
Sci Rep. 2020 Dec 3;10(1):21043. doi: 10.1038/s41598-020-77992-1.
7
Case 6-2020: A 34-Year-Old Woman with Hyperglycemia.病例6 - 2020:一名患有高血糖的34岁女性。
N Engl J Med. 2020 Feb 20;382(8):745-753. doi: 10.1056/NEJMcpc1913475.
8
Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease.人类葡萄糖激酶调节和疾病中的纳秒级动力学与构象异质性
Biophys J. 2020 Mar 10;118(5):1109-1118. doi: 10.1016/j.bpj.2019.12.036. Epub 2020 Jan 14.
9
How Heterogeneity in Glucokinase and Gap-Junction Coupling Determines the Islet [Ca] Response.葡萄糖激酶和缝隙连接偶联的异质性如何决定胰岛 [Ca] 反应。
Biophys J. 2019 Dec 3;117(11):2188-2203. doi: 10.1016/j.bpj.2019.10.037. Epub 2019 Nov 5.
10
Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.葡萄糖激酶激活突变导致的先天性高胰岛素血症性低血糖的临床和酶学表型:两例报告及文献复习
J Diabetes Investig. 2019 Nov;10(6):1454-1462. doi: 10.1111/jdi.13072. Epub 2019 Jun 12.
葡萄糖结合曲线的全局拟合分析揭示了人葡萄糖激酶中动力学协同作用的最小模型。
Biochemistry. 2010 Oct 19;49(41):8902-11. doi: 10.1021/bi1008672.
4
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study.吡格列酮(RO4389620),一种新型葡萄糖激酶激活剂,可降低 2 型糖尿病患者空腹和葡萄糖负荷后的血浆葡萄糖:一项机制研究。
J Clin Endocrinol Metab. 2010 Nov;95(11):5028-36. doi: 10.1210/jc.2010-1041. Epub 2010 Aug 25.
5
Direct evidence of conformational heterogeneity in human pancreatic glucokinase from high-resolution nuclear magnetic resonance.高分辨率核磁共振直接证明人胰腺葡萄糖激酶构象异质性。
Biochemistry. 2010 Sep 21;49(37):7969-71. doi: 10.1021/bi101098f.
6
Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent.6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶对葡萄糖激酶的内源性激活是依赖葡萄糖的。
Mol Endocrinol. 2010 Oct;24(10):1988-97. doi: 10.1210/me.2010-0115. Epub 2010 Aug 11.
7
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675).葡萄糖激酶激活剂(2R)-3-环戊基-2-(4-甲磺酰基苯基)-N-噻唑-2-基丙酰胺(RO0281675)的发现、构效关系、药代动力学和疗效。
J Med Chem. 2010 May 13;53(9):3618-25. doi: 10.1021/jm100039a.
8
Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.葡萄糖激酶(GCK)基因突变的最新研究进展,这些突变可导致青年发病的成年型糖尿病、新生儿糖尿病和高胰岛素血症性低血糖。
Hum Mutat. 2009 Nov;30(11):1512-26. doi: 10.1002/humu.21110.
9
Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states.葡萄糖和变构激活剂与人葡萄糖激酶的结合动力学揭示了多种构象状态。
Biochemistry. 2009 Jun 16;48(23):5466-82. doi: 10.1021/bi900374c.
10
Assessing the potential of glucokinase activators in diabetes therapy.评估葡萄糖激酶激活剂在糖尿病治疗中的潜力。
Nat Rev Drug Discov. 2009 May;8(5):399-416. doi: 10.1038/nrd2850. Epub 2009 Apr 17.